Very interesting proposal about trialling methods at muchea, but this is all very early stage stuff. The trials could well take many months, maybe years, and then all the results will need careful review. I cant imagine that shareholders will now want to provide the necessary funding to current management to complete these studies, given their poor track record of delivery. Its time for a complete change of people.
all imho, dyor
- Forums
- ASX - By Stock
- VRX
- Ann: Entitlement Issue Prospectus
Ann: Entitlement Issue Prospectus, page-57
-
- There are more pages in this discussion • 105 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VRX (ASX) to my watchlist
|
|||||
Last
3.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.47M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 340000 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.3¢ | 16290 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 340000 | 0.030 |
2 | 200000 | 0.029 |
1 | 100000 | 0.028 |
2 | 160000 | 0.027 |
1 | 300000 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.033 | 16290 | 1 |
0.035 | 34319 | 1 |
0.036 | 286529 | 1 |
0.037 | 76412 | 1 |
0.038 | 14000 | 1 |
Last trade - 10.09am 13/08/2024 (20 minute delay) ? |
Featured News
VRX (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online